Sosei Heptares to Receive US$3 Million Payment from Genentech on Nomination of a New GPCR Disease Target_5d9d90046f8d9.jpeg e5118797b3f9f89090dce53bb927ab53 e5118797b3f9f89090dce53bb927ab53